Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund D USD Acc U

Reference Data

ISIN IE00B00LSD17
Valor Number 1694103
Bloomberg Global ID BBG000NRR1H4
Fund Name Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund D USD Acc U
Fund Provider Wellington Management Company LLP Web: https://www.wellingtonfunds.com
Fund Provider Wellington Management Company LLP
Representative in Switzerland BNP Paribas, Paris, Zurich Branch
Zürich
Distributor(s) Wellington Global Administrator, Ltd.
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide.
Peculiarities

Fund Prices

Current Price * 52.45 USD 20.09.2024
Previous Price * 52.86 USD 19.09.2024
52 Week High * 53.67 USD 30.08.2024
52 Week Low * 40.37 USD 27.10.2023
NAV * 52.45 USD 20.09.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 2,566,143,196
Unit/Share Assets *** 856,166,738
Trading Information SIX

Performance

YTD Performance +12.87% 29.12.2023
20.09.2024
YTD Performance (in CHF) +14.09% 29.12.2023
20.09.2024
1 month -0.55% 20.08.2024
20.09.2024
3 months +7.35% 20.06.2024
20.09.2024
6 months +8.30% 20.03.2024
20.09.2024
1 year +20.25% 20.09.2023
20.09.2024
2 years +26.50% 20.09.2022
20.09.2024
3 years +3.52% 20.09.2021
20.09.2024
5 years +52.20% 20.09.2019
20.09.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 8.30%
UnitedHealth Group Inc 7.27%
Novo Nordisk A/S 5.41%
AstraZeneca PLC 4.16%
Merck & Co Inc 4.14%
Danaher Corp 2.87%
Novartis AG Registered Shares 2.82%
Boston Scientific Corp 2.39%
argenx SE 2.23%
Daiichi Sankyo Co Ltd 2.13%
Last data update 31.07.2024

Cost / Risk

TER 1.98%
TER date 15.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 1.25%
Ongoing Charges *** 1.98%
SRRI ***
SRRI date *** 31.08.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)